For children with atopic dermatitis (AD), early childhood stressful life events are associated with an increased ris ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Enveda, a biotechnology company using AI to translate nature into new medicines, is proud to announce testing of its lead asset, ENV-294, in a second indication: asthma. This novel therapeutic, ...

Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) saw some unusual options trading activity on Wednesday. Investors acquired 1,885 put options on the company. This represents an increase of ...

Healio Dermatology will be reporting live at South Beach Symposium 2025 from Feb. 6 to 8 in Miami Beach, Florida. The 23rd ...

Many people with ongoing medical conditions experience more symptoms during the winter. Here's why, and what you can do.

Alys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...

Hair and face slugging are trends that have fallen by the wayside for the newest kid on the block - face basting. Coined by a dermatologist who uses the technique herself to treat her skin overnight, ...

For the nine months ended December 31, 2024, Sonoma reported revenues of $10.5 million and cost of revenues of $6.6 million, resulting in gross profit of $3.9 million, or 37% of revenues, compared to ...

Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of AbbVie in a research note issued to investors on Monday, February 3rd. Leerink ...

Eli Lilly’s latest TV ad, unveiled during the Grammys on Sunday night, highlights the importance of early diagnosis for ...

Cadrenal Therapeutics, Inc. , a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapies, leading with tecarfarin, a new Vitamin K antagonist will ...